NCT02132117View on ClinicalTrials.gov

Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

445

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
ErythemaRosacea
Interventions
DRUG

Oxymetazoline HCL Cream 1.0%

Oxymetazoline HCL Cream 1.0% (AGN-199201) applied to the face once daily for 29 days.

DRUG

Vehicle to Oxymetazoline HCL Cream

Vehicle to Oxymetazoline HCL Cream (AGN-199201) applied to the face once daily for 29 days.

Trial Locations (1)

Unknown

College Station

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY